# Nadroparin Pharmacokinetics in Different Stages of COVID-19

> **NCT05621915** · — · COMPLETED · sponsor: **Medical University of Lublin** · enrollment: 43 (actual)

## Conditions studied

- Thrombosis
- Nadroparin
- COVID-19
- Mechanical Ventilation
- Anticoagulants and Bleeding Disorders

## Interventions

- **DRUG:** Nadroparin

## Key facts

- **NCT ID:** NCT05621915
- **Lead sponsor:** Medical University of Lublin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-04-15
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2022-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05621915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05621915, "Nadroparin Pharmacokinetics in Different Stages of COVID-19". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05621915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*